Category
Sepsis & Septic Shock
Journal
BMJ
Takeaway
Thymosin α1: no mortality benefit in unselected sepsis (HR 0.99), largest trial of its kind.
Verdict
Null / Equivalence
Year
2025
BMJ
Thymosin α1: no mortality benefit in unselected sepsis (HR 0.99), largest trial of its kind.